79 Recruiting Follicular Lymphoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Follicular Lymphoma
Related Conditions
Top Recruiting Follicular Lymphoma Studies
A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas
📍 Weill Cornell Medicine/NewYork-Presbyterian Hospital — New York, New York
View Study & Checklist ➔Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma
📍 Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Tazemetostat and Mosunetuzumab in Untreated Follicular Lymphoma
📍 Weill Cornell Medicine/NewYork-Presbyterian Hospital — New York, New York
View Study & Checklist ➔Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.
📍 John Muir Health Clinical Research Center — Concord, California
View Study & Checklist ➔A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular Lymphoma
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Study of Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma
📍 Northwestern University — Chicago, Illinois
View Study & Checklist ➔Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma
📍 Advocate Medical Group - Park Ridge, Luther Lane - Oncology — Park Ridge, Illinois
View Study & Checklist ➔Assessing the Experience of Patients Undergoing Follicular Lymphoma Clinical Research
📍 Power Life Sciences — San Francisco, California
View Study & Checklist ➔A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma
📍 Yale Cancer Center — New Haven, Connecticut
View Study & Checklist ➔Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma
📍 Florida Cancer Specialists and Research Institute — Fort Myers, Florida
View Study & Checklist ➔Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
📍 Masonic Cancer Center — Minneapolis, Minnesota
View Study & Checklist ➔A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
📍 Duke Cancer Center Clinic 1B/C Onc/Heme ( Site 1307) — Durham, North Carolina
View Study & Checklist ➔A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy
📍 Stanford Cancer Center — Palo Alto, California
View Study & Checklist ➔A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
📍 Georgetown University (Data Collection Only) — Washington D.C., District of Columbia
View Study & Checklist ➔Odronextamab in Low Tumor Volume Advanced FL
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔Clonal Evolution in Follicular Lymphoma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Epco, Zanu, Ritux for R/R FL or MZL
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
📍 Local Institution - 0225 — Birmingham, Alabama
View Study & Checklist ➔Epcoritamab and Rituximab for First-line Follicular Lymphoma
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
📍 Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting
📍 CIBMTR — Milwaukee, Wisconsin
View Study & Checklist ➔